Cataract surgery in subluxated lenses with the modified capsular tension ring

Article

Professor Boris Malyugin, professor of ophthalmology at S. Fyodorov Eye Microsurgery Complex in Moscow, Russia looks at the new modified Cionni capsular tension ring.

The Cionni capsular tension ring has been modified by Professor Boris Malyugin and can now be fully retracted inside an injector tube and implanted through a sub 2 mm corneal microincision.

Speaking at the ESCRS Congress in Paris he said: “Management of congenital and acquired zonular deficiency, such as Marfan syndrome, trauma, pseudoexfoliation syndrome, glaucoma and high myopia have been helped in the past by the endocapsular tension ring (J Cataract Refract Surg. 1998 Oct;24(10):1299-306) but the Cionni Capsular Tension Ring has not been suitable for injection.“

As Professor Malyugin explained that by moving the fixation element to the tip of the ring means it can glide safely along the capsular bag equator without violating its integrity. Duplicature of the ring tips allows for the additional support of the capsular equator opposite to the fixation element.

Experimental research in the form of an eye bank study of just 5 eyes showed easy implantation, easy rotation and easy suture fixation ensuring a stable capsular bag position. In a separate study 18 eyes of 17 patients, 8 of whom had Marfan syndrome, 8 with blunt ocular trauma, 1 with glaucoma + PEX (pseudoexfoliation syndrome) and 1 with PEX results were also promising. Preoperatively, BCVA varied from 20/50 to counting fingers and improved from 20/40 to 20/20 in all cases. The mean follow-up period was 16±4.3 months. In all patients capsular bag centration was achieved. Lens position was verified with ultrasonic biomicroscopy.

PCO (posterior capsule opacification) was the most frequent complication of postoperative period and occurred in 3 eyes, 2 of which required YAG laser capsulotomy.

The results led to Professor Malyugin’s conclusions that the Modified Cionni Capsular Tension Ring (MC CTR) is designed specifically for use during microincision cataract surgery (MICS) and it allows for capsular bag stabilization by securing it to the scleral wall. He believes it to be proven as safe, effective and to provide favourable anatomical and functional results.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
Related Content
© 2025 MJH Life Sciences

All rights reserved.